TGRX-678 Chinese Phase III in Chronic Myelogenous Leukemia (CML) Patients
Shenzhen TargetRx Co., Ltd.
Shenzhen TargetRx Co., Ltd.
Novartis
Ascentage Pharma Group Inc.
Il-Yang Pharm. Co., Ltd.
Il-Yang Pharm. Co., Ltd.
Takeda
Takeda
Hamad Medical Corporation
Bristol-Myers Squibb
Il-Yang Pharm. Co., Ltd.
INSYS Therapeutics Inc
Novartis
Novartis
Bristol-Myers Squibb